Pain Management Roundup: Addressing Gaps with Cebranopadol, Navigating Nephrolithiasis

Q&A: How Cebranopadol Could Help Address Gaps in Pain Management

Pain Management Roundup: Addressing Gaps with Cebranopadol, Navigating Nephrolithiasis / Steheap - stock.adobe.com

In a recent interview with Drug Topics, Albert Dahan, MD, PhD, professor of anesthesiology at Leiden University Medical Center, discussed how cebranopadol is different from traditional opioids, how it will fit into the broader landscape of pain management therapies, current gaps that exist in pain management and how the therapy might help address them, and what the next steps are for cebranopadol.

Navigating Nephrolithiasis: A Pharmacist's Perspective

In a conversation with Drug Topics, Garofoli provided an overview of his presentation. He spoke to the importance of balancing opioid use, promoting preventive measures, and fostering interdisciplinary collaboration in providing care for kidney stone pain, as well as emphasized the importance of storytelling to humanize patient experiences in health care.

Chronic Pain Linked to Higher Anxiety, Depression in Youth

Youth with chronic pain are more likely to experience anxiety and depression than those without chronic pain, with 1 in 3 youth and 1 in 8 youth with chronic pain meeting the criteria for either condition, respectively, according to a new study published in JAMA Pediatrics. Authors suggested that screening, prevention, and treatment of mental health should be important priorities for the patient population.

Antidepressants Found Ineffective for Treating Osteoarthritis Pain in Older Adults

After completing a meta-analysis aiming to define the best treatment option for knee osteoarthritis (OA) pain in adults 65 and over, researchers were unable to recommend antidepressants as an effective treatment for pain, despite its use in other countries and trials.

Study: A Walk a Day Keeps Low Back Pain Away

An individualized, progressive walking and education intervention may reduce low back pain recurrence in adults who are not previously engaged in regular physical activity, according to study results published in The Lancet. Study authors noted that walking represents an accessible, scalable, and safe approach to managing the condition.

New Study Examines Potential of Oxytocin as Pain Management Adjunctive, Addiction Treatment

A group of researchers from the University of Florida are conducting a study evaluating whether a synthetic version of oxytocin—a hormone naturally produced in the hypothalamus—can be used as an adjunct to prescription medications to address opioid addiction in older adults.

Excess Abdominal Fat May Contribute to Chronic Musculoskeletal Pain

A study published in Regional Anesthesia & Pain Medicine found that abdominal adipose tissue was associated with chronic musculoskeletal pain, suggesting that excessive and ectopic fat depositions may be involved in the pathogenesis of multisite and widespread chronic musculoskeletal pain. Stronger effects observed in women than men may reflect sex differences in fat distribution and hormones, according to investigators.
Tonix Pharmaceuticals Launches Campaign Promoting Non-Oral Medications for Gastroparesis, Migraine

At this year’s PAINWeek National Conference, held September 3 to 6 in Las Vegas, Nevada, Tonix Pharmaceuticals announced the launch of its new educational campaign, “Does Your Migraine Pill Work Every Time?” Targeted toward patients and health care providers, the campaign highlights the advantages of non-oral migraine treatments, such as nasal and injectable options, for individuals with gastroparesis, according to a company news release.

Are you ready to elevate your pharmacy practice? Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox.